Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Zosano Pharma Corp (ZSAN)
|
|
| Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Mar-31-22 | Dec-31-21 | Sep-30-21 | Mar-31-21 | Dec-31-20 | Sep-30-20 | Jun-30-20 | Jun-05-20 |
| | 10-Q | 10-K | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 8-K |
| Revenues | | | | 100.0% | 100.0% | 100.0% | | |
| Cost of goods sold | | | | 69.1% | 76.3% | 156.1% | | |
| Gross profit | | | | 30.9% | 23.7% | -56.1% | | |
| Research and development | | | | 4447.7% | 9652.7% | 344.3% | | |
| General and administrative | | | | 2265.8% | 4995.1% | 236.3% | | |
| Depreciation | | | | 350.4% | 636.6% | 16.5% | | |
| EBIT | | | | -6682.6% | -14624.1% | -680.6% | | |
| Pre-tax income | | | | -6809.5% | -14896.9% | -693.7% | | |
| Income taxes | | | | 0.0% | 0.0% | 0.0% | | |
| Net income | | | | -6809.5% | -14896.9% | -693.7% | | |
|